Report cover image

Human Reproductive Technologies Market, By Technology (Infertility Drugs, Contraceptive Drugs and Devices), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2

Publisher Coherent Market Insights
Published May 14, 2022
Length 181 Pages
SKU # CMI17212341

Description

Human Reproductive Technologies Market, By Technology (Infertility Drugs, Contraceptive Drugs and Devices), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Human reproductive technologies assist parents who are having troubles in pregnancies, and infertility issues. These technologies include Assisted Reproductive Technology (ART), prognostics, contraception, and same-sex procreation. ART aids in the treatment of low fertility or infertility using artificial insemination, artificial reproduction, cloning, cytoplasmic transfer, fertility medication, hormone treatment, and others.

Restraints of the Global Human Reproductive Technologies Market
Major factors hampering the growth of the human reproductive technologies market during the forecast period constitutes of limited insurance coverage for ART, and low adoption of emergency human reproductive technologies in emerging economies.
Key features of the study:
This report provides in-depth analysis of the global human reproductive technologies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global human reproductive technologies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, Evofem Biosciences, Inc., Actavis Generics (Teva Pharmaceutical Industries Ltd.), Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Uniprix, Gavis Pharmaceuticals (Lupin Limited), Sandoz International GmbH, Aurobindo Pharma Limited, HRA Pharma, SA, Mankind Pharma, Cryos USA, Merck & Co, Bayer HealthCare AG, Church & Dwight, Co. Inc., Allergan, Pfizer, Inc., Agile Therapeutics Inc., BioSante Pharmaceuticals Inc., Mayer Laboratories, Inc., Pantarhei Bioscience B.V., Cook Medical, Inc., Ferring Pharmaceuticals, Johnson & Johnson, Daré Bioscience, Inc., and Merck Serono.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global human reproductive technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Human Reproductive Technologies Market, By Technology:
Infertility Drugs
Contraceptive Drugs and Devices
Global Human Reproductive Technologies Market, By Geography:
North America
By Technology
Infertility Drugs
Contraceptive Drugs and Devices
By Country:
U.S.
Canada
Europe
By Technology
Infertility Drugs
Contraceptive Drugs and Devices
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Technology
Infertility Drugs
Contraceptive Drugs and Devices
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Technology
Infertility Drugs
Contraceptive Drugs and Devices
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Technology
Infertility Drugs
Contraceptive Drugs and Devices
By Country:
GCC
Israel
Rest of Middle East
Africa
By Technology
Infertility Drugs
Contraceptive Drugs and Devices
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Abbott Laboratories*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Evofem Biosciences, Inc.
Actavis Generics (Teva Pharmaceutical Industries Ltd.)
Sun Pharmaceutical Industries Ltd.
Perrigo Company plc
Uniprix
Gavis Pharmaceuticals (Lupin Limited)
Sandoz International GmbH
Aurobindo Pharma Limited
HRA Pharma, SA
Other Major Players
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

181 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Technology
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Technological Advancement
Regulatory Scenario
4. Global Human Reproductive Technologies Market, By Technology, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Infertility Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Contraceptive Drugs and Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
5. Global Human Reproductive Technologies Market, By Regions, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
North Africa
Central Africa
South Africa
6. Competitive Landscape
Company Profiles
Abbott Laboratories
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Evofem Biosciences, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Actavis Generics (Teva Pharmaceutical Industries Ltd.)
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Sun Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Perrigo Company plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Uniprix
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Gavis Pharmaceuticals (Lupin Limited)
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Sandoz International GmbH
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Aurobindo Pharma Limited
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
HRA Pharma, SA
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Other Major Players
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
7. Section
References
Research Methodology
About us and Sales Contact
*Browse 33 market data tables and 24 figures on “Human Reproductive Technologies Market – Global forecast to 2028.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us